Effects of the 5-HT 6 receptor agonist ST 1936 on depression- and anhedonia-like experimental models

Behavioural Brain Research

Volumn 224, Issue 1, 2011, Pages 35-43

  Scheggi, Simona ^a   Marchese, Giovanna ^a   Borsini, Franco ^b   Bordi, Fabio ^b   De Montis, Maria Graziella ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Sigma Tau SpA   (Italy)

Author keywords

5 HT 6 receptor; Anhedonia; Antidepressants; Appetitive behavior; Unavoidable stress

Indexed keywords

2 (5 CHLORO 2 METHYL 1H INDOL 3 YL) N,N DIMETHYLETHANAMINE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; ANTIDEPRESSANT AGENT; SEROTONIN 6 AGONIST; SEROTONIN AGONIST; ST 1936; UNCLASSIFIED DRUG;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ESCAPE BEHAVIOR; HABITUATION; LOCOMOTION; MALE; NONHUMAN; PAIN THRESHOLD; PLASTICITY; PRIORITY JOURNAL; RAT; STRESS; VANILLA;

ANALYSIS OF VARIANCE; ANIMALS; APPETITIVE BEHAVIOR; BENZAZEPINES; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ELECTROSHOCK; ESCAPE REACTION; ETHYLAMINES; FOOD PREFERENCES; INDOLES; MALE; MOTOR ACTIVITY; PAIN THRESHOLD; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; SWEETENING AGENTS; TIME FACTORS;

EID: 79958809182     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.05.019     Document Type: Article

References (74)

1. Kendall I., Slotten H.A., Codony X., Burgueno J., Pauwels P.J., Vela J.M., et al. E-6801, a 5-HT(6) receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. Psychopharmacology (Berlin) 2011, 213:413-430.
2. 6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology 2001, 158:114-119.
3. 6 receptor-mediated mechanism. Neuropharmacology 2006, 50:412-420.
4. Mitchell E.S. 5-HT6 receptor ligands as antidemential drugs. Int Rev Neurobiol 2011, vol. 96:163-187. F. Borsini (Ed.).
5. 6 receptor blockade improves spatial recognition memory and reverses age-related deficits in spatial recognition memory in the mouse. Neuropsychopharmacology 2009, 34:488-500.
6. 6 receptor antagonist. J Psychopharmacol 2004, A27.
7. King M.V., Sleight A.J., Woolley M.L., Topham I.A., Marsden C.A., Fone K.C. 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation - an effect sensitive to NMDA receptor antagonism. Neuropharmacology 2004, 47:195-204.
8. 6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol 2006 2006, 553:109-119.
9. 6 receptor antagonist Ro 04-6790 on learning consolidation. Behav Brain Res 2001, 118:107-110.
10. 6 receptor antagonist. J Med Chem 2003, 46:1273-1276.
11. 6 receptor-mediated acetylcholine release. Eur J Neurosci 2006, 24:1299-1306.
12. Burnham K.E., Baxter M.G., Bainton J.R., Southam E., Dawson L.A., Bannerman D.M., et al. Activation of 5HT(6) receptors facilitates attentional set shifting. Psychopharmacology (Berlin) 2010, 208:13-21.
13. 6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology (Berlin) 2005, 181:253-259.
14. 6 receptors inconsistencies. Pharmacol Biochem Behav 2011, 98:169-172.
15. Roberts J.C., Reavill C., East S.Z., Harrison P.J., Patel S., Routledge C., et al. The distribution of 5HT(6) receptors in rat bra an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585. Brain Res 2002, 934:49-57.
16. 6 serotonin receptor. J Neurochem 1996, 66:47-56.
17. 6 receptor mRNA in the central nervous system of control or 5,7dihydroxytryptamine-treated rats. Synapse 1996, 23:164-173.
18. 6 receptor-like material in the rat central nervous system. Brain Res 1997, 746:207-219.
19. Monsma F.J., Shen Y., Ward R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 1993, 43:320-327.
20. 6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop. Brain Res Mol Brain Res 2001, 90:110-117.
21. Wesołowska A., Jastrzebska-Wiesek M. Behavioral pharmacology: potential antidepressant and anxiolytic properties. Int Rev Neurobiol 2011, vol. 96:49-71. F. Borsini (Ed.).
22. 6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder. Psychiatr Clin Neurosci 2005, 59:140-145.
23. Gennarelli M., Cattaneo A Genetic variation and association. Int Rev Neurobiol 2010, vol. 94:129-152. F. Borsini (Ed.).
24. 6 and 5-HT7 receptor gene expression in the rat hippocampus. Mol Brain Res 1997, 45:182-186.
25. 6 receptor antagonist. J Med Chem 1999, 42:202-205.
26. 6 receptors. Br J Pharmacol 1999, 127:23P.
27. 6 receptors in rat, pig and human brain tissue. Br J Pharmacol 2000, 130:1597-1605.
28. 6vantagonists in the rat forced swimming test: Potential therapeutic utility in mood disorders associated with Alzheimer's disease. Life Sci 2009, 84:558-562.
29. Wesolowska A. Potential role of receptors in depression and anxiety: an overview of preclinical data. Pharmacol Rep 2010, 62:564-567.
30. 6 receptor antagonists SB-3999885 in animal models of anxiety and depression. Neuropharmacology 2007, 52:1274-1283.
31. 6 receptor agonists in rats. Psychopharmacology 2011, 213:499-507.
32. 6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 2008, 33:1323-1335.
33. 6 receptor stimulation. J Neurosci 2007, 27:4201-4209.
34. De Foubert G., O'Neill M.J., Zetterstrom T.S. Acute onset by 5-HT(6)-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression. Neuroscience 2007, 147:778-785.
35. 6 receptor antagonist SB-399885 in rats. Pharmacol Rep 2007, 59:664-671.
36. 6 receptor antagonist SB-258585 after the intrahippocampal administration to rats. Behav Pharmacol 2007, 18:439-446.
37. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activityŽ. Psychopharmacology 1988, 94:147-160.
38. Gambarana C., Ghiglieri O., Taddei I., Tagliamonte A., De Montis M.G. Imipramine and fluoxetine prevent the stress induced escape deficits in rats through a distinct mechanism of action. Behav Pharmacol 1995, 6:66-73.
39. Meloni D., Gambarana C., De Montis M.G., Dal Prà P., Taddei I., Tagliamonte A. Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats. Pharmacol Biochem Behav 1993, 46:423-426.
40. Borsini F, Stasi MA, Minetti P, Riccioni T, Mennini T. Effect of ST 1936, a 5HT6 ligand, on rodent adenylate cyclase and forced swimming test. In: CINP Biennial international congress, Munich P-01.109; 2008.
41. 6 receptors. Eur J Pharmacol 2011, 661(1-3):8-14.
42. 6 receptor agonist. Neuropharmacology 2010, 60(4):602-608.
43. Gambarana C., Ghiglieri O., Tagliamonte A., D'Alessandro N., De Montis M.G. Crucial role of D1 dopamine receptors in mediating the antidepressant effect of imipramine. Pharmacol Biochem Behav 1995, 50(2):147-151.
44. Ghiglieri O., Gambarana C., Scheggi S., Tagliamonte A., Willner P., De Montis M.G. Palatable food induces an appetitive behaviour in satiated rats which can be inhibited by chronic stress. Behav Pharmacol 1997, 8:619-628.
45. Gambarana C., Scheggi S., Tagliamonte A., Tolu P., et al. Animal models for the study of antidepressant activity. Brain Res Protoc 2001, 7:11-20.
46. Gambarana C., Masi F., Leggio B., Grappi S., Nanni G., Scheggi S., et al. Acquisition of a palatable-food-sustained appetitive behavior in satiated rats is dependent on the dopaminergic response to this food in limbic areas. Neuroscience 2003, 121:179-187.
47. Di Chiara G. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res 2002, 137:75-114.
48. De Montis M.G., Gambarana C., Ghiglieri O., Tagliamonte A. Reversal of stable behavioural modifications through NMDA receptor inhibition in rats. Behav Pharmacol 1995, 6:562-567.
49. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941, 72:74-79.
50. Scheggi S., Raone A., De Montis M.G., Tagliamonte A., Gambarana C. Behavioral expression of cocaine sensitization in rats is accompanied by a distinct pattern of modifications in the PKA/DARPP-32 signaling pathway. J Neurochem 2007, 103(3):1168-1183.
51. Grappi S., Nanni G., Leggio B., Rauggi R., Scheggi S., Masi F., et al. The efficacy of reboxetine in preventing and reverting a condition of escape deficit in rats. Biol Psychiatr 2003, 53(10):890-898.
52. Rauggi R., Cassanelli A., Raone A., Tagliamonte A., Gambarana C. Study of mirtazapine antidepressant effects in rats. Int J Neuropsychopharmacol 2005, 8(3):369-379.
53. 6 receptor antagonist Ro 04-6790, in rats. Brit J Pharmacol 1999, 126:1537-1542.
54. 6 receptors in nigro-striatal function in rodents. Brit J Pharmacol 1998, 125:1562-1566.
55. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93:358-364.
56. McArthur R., Borsini F. Animal models of depression in drug discovery: a historical perspective. Pharmacol Biochem Behav 2006, 84:436-452.
57. Willner P., Muscat R., Papp M. Chronic mild stress-induced anhedonia. A realistic animal model of depression. Eur J Pharmacol 1992, 296:129-136.
58. Muscat R., Sampson D., Willner P. Dopaminergic mechanisms of imipramine action in an animal model of depression. Biol Psychiatr 1990, 28:223-230.
59. Muscat R., Papp M., Willner P. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology 1992, 109:433-438.
60. Papp M., Willner P., Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 1991, 104:255-259.
61. Papp M., Moryl E., Willner P. Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol 1996, 296:129-136.
62. Moreau J.-L., Jenck F., Martin J.R., Mortas P., Haefely W.E. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol 1992, 2:43-49.
63. Willner P. Validity reliability and utility of the chronic mild stress model of depression: a ten-year review and evaluation. Psychopharmacology 1997, 134:319-329.
64. 6 receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacology 2004, 29:93-100.
65. 6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 2001, 41:210-219.
66. 6 receptors in learning and memory. Trends Pharmacol Sci 2008, 29(9):482-492.
67. 6 receptor memory and amnesia: behavioral pharmacology - learning and memory processes. Int Rev Neurobiol 2011, vol. 96:27-47. F. Borsini (Ed.).
68. 6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacol Biochem Behav 2005, 81:673-682.
69. 6) receptor antagonists in rodent models of learning. J Pharmacol Exp Ther 2003, 307:682-691.
70. 6 receptor ligands and their biological functions. Curr Top Med Chem 2002, 2:643-654.
71. Dickinson A., Balleine B.W., Watt A., Gonzales F., Boakes R.A. Overtraining and the motivational control of instrumental action. Anim Learn Behav 1995, 22:197-206.
72. Tolu P., Masi F., Leggio B., Scheggi S., Tagliamonte A., De Montis M.G., et al. Effect of long-term acetyl-l-carnitine administration in rats: I. Increased dopamine outputin mesocorticolimbic areas and protection toward acute stress exposure. Neuropsychopharmacology 2002, 27:410-420.
73. Masi F., Leggio B., Nanni G., Scheggi S., De Montis M.G., Tagliamonte A., et al. Effects of long-term acetyl-l-carnitine administration in rats II: protection against the disrupting effect of stress on the acquisition of appetitive behavior. Neuropsychopharmacology 2003, 28:683-693.
74. Ulrich-Lai Y.M., Christiansen A.M., Ostrander M.M., Jones A.A., Kenneth R., Jones K.R., et al. Pleasurable behaviors reduce stress via brain reward pathways. PNAS 2010, 107:20529-20534.